Pharmacy Times® interviewed Jason Valent, MD, of the Cleveland Clinic his recent CAEL-101 findings, and how it can help shape treatment for patients living with amyloid light chain amyloidosis. His research surrounding the therapy was presented at the 62nd American Society of Hematology Annual Meeting & Exposition.

The full conversation can be found in the video above.